Skip to main content

letter

. 1992 Nov 7;305(6862):1160. doi: 10.1136/bmj.305.6862.1160-b

Radioiodine for hyperthyroidism.

D O'Halloran, S M Shalet

PMCID: PMC1883698 PMID: 1463967

1160

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Ahmed S. R., Shalet S. M. Gonadal damage due to radioactive iodine (I131) treatment for thyroid carcinoma. Postgrad Med J. 1985 Apr;61(714):361–362. doi: 10.1136/pgmj.61.714.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
Franklyn J., Sheppard M. Radioiodine for hyperthyroidism. BMJ. 1992 Sep 26;305(6856):727–728. doi: 10.1136/bmj.305.6856.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
Handelsman D. J., Turtle J. R. Testicular damage after radioactive iodine (I-131) therapy for thyroid cancer. Clin Endocrinol (Oxf) 1983 May;18(5):465–472. doi: 10.1111/j.1365-2265.1983.tb02876.x. [DOI] [PubMed] [Google Scholar]
Raymond J. P., Izembart M., Marliac V., Dagousset F., Merceron R. E., Vulpillat M., Vallée G. Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine. J Clin Endocrinol Metab. 1989 Jul;69(1):186–190. doi: 10.1210/jcem-69-1-186. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES